lenalidomide has been researched along with Crohn Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akobeng, AK; Srinivasan, R | 1 |
| Akobeng, AK; Stokkers, PC | 1 |
| Cooper, A; Forbes, A; Hawkey, CJ; Hawthorne, AB; Manning, DC; Mansfield, JC; Parkes, M; Perowne, RC; Probert, CS; Zeldis, JB | 1 |
2 review(s) available for lenalidomide and Crohn Disease
| Article | Year |
|---|---|
Thalidomide and thalidomide analogues for induction of remission in Crohn's disease.
Topics: Crohn Disease; Humans; Immunosuppressive Agents; Lenalidomide; Randomized Controlled Trials as Topic; Remission Induction; Thalidomide; Tumor Necrosis Factor-alpha | 2009 |
Thalidomide and thalidomide analogues for maintenance of remission in Crohn's disease.
Topics: Crohn Disease; Humans; Immunosuppressive Agents; Lenalidomide; Remission Induction; Thalidomide; Tumor Necrosis Factor-alpha | 2009 |
1 trial(s) available for lenalidomide and Crohn Disease
| Article | Year |
|---|---|
A randomized, double-blind, placebo-controlled trial of lenalidomide in the treatment of moderately severe active Crohn's disease.
Topics: Adolescent; Adult; Aged; Crohn Disease; Double-Blind Method; Female; Humans; Immunosuppressive Agents; Lenalidomide; Male; Middle Aged; Placebos; Severity of Illness Index; Thalidomide; Treatment Outcome; Venous Thrombosis | 2007 |